AI maps how a new antibiotic targets gut bacteria
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
Biogen groundbreaking stirs optimism in Kendall Square
The gathering of Biogen and MIT employees, business leaders, and public officials celebrated the first building to be constructed at Kendall Common.
MIT researchers develop AI tool to improve flu vaccine strain selection
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
A new model predicts how molecules will dissolve in different solvents
Solubility predictions could make it easier to design and synthesize new drugs, while minimizing the use of more hazardous solvents.
Using generative AI, researchers design compounds that can kill drug-resistant bacteria
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
New system dramatically speeds the search for polymer materials
The platform identifies, mixes, and tests up to 700 new polymer blends a day for applications like protein stabilization, battery electrolytes, or drug-delivery materials.
MIT launches a “moonshot for menstruation science”
The Fairbairn Menstruation Science Fund will allow researchers to accelerate the understanding and treatment of often-neglected diseases that tend to be more common in women.
Supercharged vaccine could offer strong protection with just one dose
By delivering an HIV vaccine candidate along with two adjuvants, researchers showed they could generate many more HIV-targeting B cells in mice.
Startup’s biosensor makes drug development and manufacturing cheaper
Protein sensor developed by alumna-founded Advanced Silicon Group can be used for research and quality control in biomanufacturing.
Once-a-week pill for schizophrenia shows promise in clinical trials
The ingestible capsule forms a drug depot in the stomach, gradually releasing its payload and eliminating the need for patients to take medicine every day.
A new computational framework illuminates the hidden ecology of diseased tissues
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
Equipping living cells with logic gates to fight cancer
Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.
Biogen to consolidate operations in MIT’s first Kendall Common building
New global headquarters will further solidify the company’s pioneering role in the Kendall Square innovation ecosystem.
Toward video generative models of the molecular world
Starting with a single frame in a simulation, a new system uses generative AI to emulate the dynamics of molecules, connecting static molecular structures and developing blurry pictures into videos.
MIT researchers introduce Boltz-1, a fully open-source model for predicting biomolecular structures
With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.